AZD4635 Relative Bioavailability Study
Condition:  Healthy Volunteers Interventions:  Drug: AZD4635 50 mg nano-suspension (reference);  Drug: AZD4635 solid oral formulation - fasted;  Drug: AZD4635 solid oral formulation - fed;  Drug: Lansoprazole and AZD4635 50 mg solid oral formulation;  Drug: AZD4635 solid oral formulation variant 1 - fasted;  Drug: AZD4635 solid oral formulation variant 2 - fasted;  Drug: [14C] AZD4635 IV microtracer - fasted Sponsors:  AstraZeneca;  Quotient Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials